The United States Evolocumab Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031. United States Evolocumab Market By Application Primary Hyperlipidemia Homozygous Familial Hypercholesterolemia Secondary Hyperlipidemia […]
Recent News